174 filings
Page 6 of 9
8-K
cq2iz81vie0daqvb3ld
30 Dec 16
Entry into a Material Definitive Agreement
12:00am
8-K
5n63cut ii2
9 Nov 16
Intrexon Announces Third Quarter 2016 Financial Results
12:00am
8-K
rerwcnf2zlzccj 7hz
3 Nov 16
Entry into a Material Definitive Agreement
12:00am
8-K
cgvypbmrgqv2vv
9 Aug 16
Intrexon Announces Second Quarter and First Half 2016 Financial Results
12:00am
8-K
hgs59lqj4wb1ixwfl
8 Aug 16
Intrexon Appoints Dr. Andrew J. Last as Chief Operating Officer
12:00am
8-K/A
m3ei4
1 Jul 16
Entry into a Material Definitive Agreement
12:00am
8-K
mbc529gogl0ph
30 Jun 16
Intrexon Appoints Fred Hassan, Distinguished Life Sciences Executive, to Board of Directors
12:00am
8-K
eja68j 4k7z6lps9p308
30 Jun 16
Intrexon and ZIOPHARM Amend Exclusive Channel Collaborations to Improve Alignment as Programs Advance through Development
12:00am
8-K
3mz0u38x tgu55m0tz
13 Jun 16
Departure of Directors or Certain Officers
12:00am
8-K
ipb 23wu1y
6 Jun 16
Intrexon Announces Retirement of Samuel Broder, M.D., Head of Health Sector
12:00am
8-K
17w2dz3hi
17 May 16
Intrexon Appoints Geno Germano to New Role of President
12:00am
8-K
0qc3rsdiil
10 May 16
Intrexon Announces First Quarter 2016 Financial Results
12:00am
8-K
qxwxu40xz
4 May 16
Regulation FD Disclosure
12:00am
8-K
lyzlbh 4mmadbb3s4
21 Mar 16
Departure of Directors or Certain Officers
12:00am
8-K
hsq99
14 Mar 16
Amendments to Articles of Incorporation or Bylaws
12:00am
8-K
s2e2v6jvl w8qccyg
29 Feb 16
Intrexon Announces Fourth Quarter and Full Year 2015 Financial Results
12:00am
8-K
z9yd6cc 8dcnm8h
13 Jan 16
Regulation FD Disclosure
12:00am
8-K
drgdm2lqzxuz3
3 Dec 15
Other Events
12:00am
8-K
w85bbh0tejv
12 Nov 15
Regulation FD Disclosure
12:00am
8-K
b00c79adqw4zcp71czm2
12 Nov 15
Entry into a Material Definitive Agreement
12:00am